Astradyne

AstradyneAstradyne
A

Astradyne

Astradyne is a startup focused on developing advanced AI for scientific discovery and research.

2023InactiveSan Francisco, United States
Rate

About

Astradyne is an early-stage company leveraging artificial intelligence to accelerate scientific research and discovery. Their technology aims to assist researchers in areas such as drug discovery, materials science, and complex data analysis, by providing powerful AI-driven tools and insights.

Technology stack

detected 2026-05-25
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Astradyne do?

Astradyne is an early-stage company leveraging artificial intelligence to accelerate scientific research and discovery. Their technology aims to assist researchers in areas such as drug discovery, materials science, and complex data analysis, by providing powerful AI-driven tools and insights.

How much funding has Astradyne raised?

Astradyne has raised a total of $2M in funding. The most recent round on record is Seed.

Where is Astradyne headquartered?

Astradyne is headquartered in San Francisco, United States.

When was Astradyne founded?

Astradyne was founded in 2023.

What industry does Astradyne operate in?

Astradyne operates in AI Infrastructure, Drug Discovery, Materials Science, Scientific Research, Foundation Model, Generative AI.

What is Astradyne's current status?

Astradyne's current operating status is: Inactive.

What is Astradyne's revenue?

StartupHub estimates Astradyne's annual revenue at $563K (range $77K to $1.4M, 32% confidence), based on comparable companies in the sector.

What is Astradyne's valuation?

StartupHub estimates Astradyne's effective valuation at $8.5M (range $5.4M to $13.0M, 18% confidence), based on comparable companies in the sector.